company background image
539871 logo

Thyrocare Technologies BSE:539871 Stock Report

Last Price

₹561.45

Market Cap

₹29.7b

7D

-9.0%

1Y

33.2%

Updated

27 Mar, 2024

Data

Company Financials +

Thyrocare Technologies Limited

BSE:539871 Stock Report

Market Cap: ₹29.7b

539871 Stock Overview

Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India.

539871 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth4/6
Past Performance1/6
Financial Health5/6
Dividends2/6

Thyrocare Technologies Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Thyrocare Technologies
Historical stock prices
Current Share Price₹561.45
52 Week High₹722.00
52 Week Low₹416.00
Beta0.53
1 Month Change-10.82%
3 Month Change-14.50%
1 Year Change33.19%
3 Year Change-37.82%
5 Year Change6.08%
Change since IPO-9.15%

Recent News & Updates

Recent updates

Shareholder Returns

539871IN HealthcareIN Market
7D-9.0%3.4%2.5%
1Y33.2%62.6%47.3%

Return vs Industry: 539871 underperformed the Indian Healthcare industry which returned 63.7% over the past year.

Return vs Market: 539871 underperformed the Indian Market which returned 48.6% over the past year.

Price Volatility

Is 539871's price volatile compared to industry and market?
539871 volatility
539871 Average Weekly Movement4.2%
Healthcare Industry Average Movement6.2%
Market Average Movement6.6%
10% most volatile stocks in IN Market10.1%
10% least volatile stocks in IN Market4.0%

Stable Share Price: 539871 has not had significant price volatility in the past 3 months.

Volatility Over Time: 539871's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19961,645Rahul Guhahttps://www.thyrocare.com

Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates in three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, COVID, and various infectious diseases.

Thyrocare Technologies Limited Fundamentals Summary

How do Thyrocare Technologies's earnings and revenue compare to its market cap?
539871 fundamental statistics
Market cap₹29.73b
Earnings (TTM)₹654.50m
Revenue (TTM)₹5.54b

45.4x

P/E Ratio

5.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
539871 income statement (TTM)
Revenue₹5.54b
Cost of Revenue₹2.87b
Gross Profit₹2.67b
Other Expenses₹2.02b
Earnings₹654.50m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)12.36
Gross Margin48.24%
Net Profit Margin11.82%
Debt/Equity Ratio9.6%

How did 539871 perform over the long term?

See historical performance and comparison

Dividends

3.2%

Current Dividend Yield

0%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.